Tag: 250/50

Posted on

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler;   Drug: Placebo inhalation powders via ELLIPTA inhaler;   Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler;   Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler;   Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified November 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days